Company news

На странице:
In early November, IPHARMA, a company of ChemRar Group, received two approvals from the Ministry of Healthcare of the ...
17.11.2017
On November 14–16, the 21st Russian Oncology Congress was held in Moscow. It is the largest international event in the ...
16.11.2017
October 30, 20017. IPHARMA, a company of ChemRar Group, was authorized by the Ministry of Healthcare of the Russian ...
31.10.2017
On November 8 at 11 a.m., IPHARMA, a company of ChemRar Group, will conduct a webinar on the topic “Opportunities for ...
30.10.2017
Technopark SKOLKOVO held a panel discussion on the topics “Civilization is (not) at risk in an age of artificial ...
19.10.2017
The Scientific Symposium “The First in the 21st Century. Innovations in Russian HIV treatment”, dedicated to the ...
13.10.2017
On October 5, 2017 in St. Petersburg as part of the Second Forum on HIV, the Viriom company of ChemRar Group conducts a ...
03.10.2017
On September 14–15, 2017 ChemRar Group presented their innovative developments at the Biotechmed-2017 conference in ...
22.09.2017
On September 14, IPHARMA celebrated the fifth anniversary of the work in the market of clinical trials in the loft on ...
15.09.2017
Conjugate, a company of ChemRar Group and the resident of the BioMedical Cluster of the Skolkovo Foundation, has ...
11.09.2017
Moscow, June 24, 2017 — ELPIDA® (elsulfavirin), a new generation non-nucleoside reverse transcriptase inhibitor (NNRTI) ...
25.07.2017
At the St. Petersburg International Economic Forum held at the site of ASI Boiling Point, Andrey Ivashchenko, the ...
02.06.2017